Drug Card Pradaxa 3g265x

Trade Name: Pradaxa

Generic Name: dabigatran

Pt Weight: 96.6kg

Classification: anticoagulant Indications: To reduce the risk of stroke/systemic embolization associated with nonvalvular atrial fibrillation Why is your patient taking this drug? Past history of CVA and Atrial Fibrillation Standard doses and routes: PO: (Adults) 150 mg twice daily Patient Dose: same as standard Adverse Reactions & Side Fx: GI: abdominal pain, diarrhea, dyspepsia, gastritis, nausea Hemat: BLEEDING, thrombocytopenia Misc: ANGIOEDEMA, HYPERSENSITIVITY REACTIONS INCLUDING ANAPHYLAXIS * CAPITALS indicate life-threatening. Italics indicate most frequent.

Patient/Family Teaching:

1. Instruct patient to take dabigatran as directed. Take missed doses as soon as ed within 6 hr. If <6 hr until next dose, skip dose and take next dose when Contraindications: scheduled; do not double doses. Do not discontinue Hypersensitivity; without consulting health Active pathological bleeding; care professional. If Concurrent use of P-glycoprotein (P-gp) inducers; temporarily discontinued, Prosthetic heart valves (mechanical or bioprosthetic) restart as soon as possible. Store dabigatran Nursing Implications: at room temperature. After opening bottle, use within 1. Monitor patient for signs of bleeding. If bleeding occurs, 4 mo; discard unused stop drug, investigate cause, and provide ive dabigatran after 4 mo. measures. There is no antidote for dabigatran 2. Inform patient that they 2. Monitor ECT or aPPT to assess treatment effectiveness may bleed more easily or 3. Discontinue dabigatran 1 to 2 days before invasive or longer than usual. Advise surgical procedures in patients with Creatinine clearance of patient to notify health care 50ml/min or more and 3 to 5 days in patients with Creatinine professional immediately if clearance of less than 50ml/min. Consider longer times for signs of bleeding (unusual patients undergoing major surgery, spinal puncture, or bruising; pink or brown placement of a spinal or epidural catheter or port, in whom urine; red or black, tarry complete hemostasis may be required stools; coughing up blood;

Trade Name: Pradaxa

Generic Name: dabigatran

Lab Test Considerations: May increase activated partial thromboplastin time (aPTT), ecarin clotting time (ECT), and thrombin time

Pt Weight: 96.6kg stools; coughing up blood; vomiting blood; pain or swelling in a t; headache; dizziness; weakness; recurring nose bleeds; unusual bleeding from gums; heavier than normal menstrual bleeding; dyspepsia; abdominal pain; epigastric pain) occur.. 3. Advise patient to notify health care professional of medication regimen prior to treatment or surgery. 4. Instruct patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal products being taken and consult health care professional before taking any new medications.